| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | Director | Common Stock | 32.7K | $1.24M | $37.98 | 15 May 2025 | Direct |
| Ultragenyx Pharmaceutical Inc. | Director | Stock Option (Right to Buy) | 10.8K | 15 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | 15 May 2025 | 2 | $0 | 4 | Director | 19 May 2025, 18:32 |
| RARE | Ultragenyx Pharmaceutical Inc. | 18 Jun 2024 | 2 | $0 | 4 | Director | 20 Jun 2024, 14:24 |
| RARE | Ultragenyx Pharmaceutical Inc. | 07 Jun 2023 | 2 | $0 | 4 | Director | 09 Jun 2023, 14:30 |
| RARE | Ultragenyx Pharmaceutical Inc. | 24 Jun 2022 | 2 | $0 | 4 | Director | 28 Jun 2022, 13:51 |
| RARE | Ultragenyx Pharmaceutical Inc. | 24 Jun 2021 | 2 | $0 | 4 | Director | 28 Jun 2021, 18:23 |